A. Holm (Oslo, Norway), C. Robinson (Zürich, Switzerland), J. Lordan (Newcastle upon Tyne (Tyne and Wear), United Kingdom), F. Meloni (Pavia (PV), Italy)
LSC - 2018 - Development of a hybrid alginate-ECM hydrogel as a potential bioink for 3D bioprinting
M. De Santis, C. Ota (chipaota@gmail.com / Comprehensive Pneumology Center (CPC), H. Zentrum Munich,Munich), R. Costa (rita.costa@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC), H. Zentrum Munich,Munich), A. Doryab (ali.doryab@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC), H. Zentrum Munich,Munich), H. N. Alsafadi (hani.alsafadi@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC), H. Zentrum Munich,Munich), D. Bolukbas (deniz.bolukbas@med.lu.se / Department of Experimental Medical Sciences, L. University,Lund), M. Konigshoff (MELANIE.KOENIGSHOFF@UCDENVER.EDU / Department of Medicine, U. of Colorado,Denver), D. E. Wagner (darcy.wagner@med.lu.se / Department of Experimental Medical Sciences, L. University,Lund)
|  |
LSC - 2018 - Laser-capture microdissection, mass spectrometry and immunohistochemistry reveal pathologic alterations in the extracellular matrix of transplanted lungs
C. Mueller, E. Ahrman (emma.ahrman@med.lu.se / Lung Biology Unit, D. of Experimental Medical Science and Division of Infection Medicine, D. of Clinical Sciences, L. University,Lund), L. T. Eriksson (leif.eriksson@med.lu.se / Lung Biology Unit, D. of Experimental Medical Science, L. University and Department of Respiratory Medicine and Allergology, L. University Hospital,Lund), K. Wassilew (katharina.wassilew@regionh.dk / Department of Pathology, C. University Hospital, R. , H. H. Schultz (Hans.Henrik.Lawaetz.Schultz.01@regionh.dk / Section for Lung Transplantation, D. of Cardiology, C. University Hospital, R. , H. Brunnstroem (hans.brunnstrom@med.lu.se / Department of Clinical Sciences in Lund, D. of Oncology and Pathology, L. University and Department of Genetics and Pathology, D. of Laboratory Medicine, R. Skåne,Lund), M. Perch (Michael.perch@regionh.dk / Section for Lung Transplantation, D. of Cardiology, C. University Hospital, R. , M. Iversen (martin@iversen-net.dk / Section for Lung Transplantation, D. of Cardiology, C. University Hospital, R. , J. Malmstroem (johan.malmstrom@med.lu.se / Division of Infection Medicine, D. of Clinical Sciences Lund, L. University,Lund), G. Westergren-Thorsson (gunilla.westergren-thorsson@med.lu.se / Lung Biology Unit, D. of Experimental Medical Science, L. University,Lund)
| |
Safety of antifibrotic drugs in idiopathic pulmonary fibrosis patients awaiting lung transplantation
R. Chirinos Guevara (barcelona, Spain), E. Vélez (barcelona, Spain), C. Berastegui (barcelona, Spain), A. Villar (barcelona, Spain), E. Revilla (barcelona, Spain), H. Sintes (barcelona, Spain), B. Sáez (barcelona, Spain), M. López Meseguer (barcelona, Spain), C. Bravo (barcelona, Spain), V. Monforte (barcelona, Spain), A. Roman (barcelona, Spain), I. Bello (barcelona, Spain), J. Sacanell (barcelona, Spain)
| |
Significant associations between Escape-avoidance coping and emotional distress in patients evaluated for lung transplant
T. Soyseth (Oslo, Norway), M. Dew (Pittsburgh PA, United States of America), M. Lund (Oslo, Norway), G. Haugstad (Oslo, Norway), V. Soyseth (Lorenskog, Norway), U. Malt (Oslo, Norway)
| |
Cardiovascular Autonomic Control in Lung Transplantation Recipients
V. Rossetti (Milan, Italy), G. Coti Zelati (Milan, Italy), E. Tobaldini (Milan, Italy), L. Morlacchi (Milan, Italy), D. Briganti (Milan, Italy), L. Bassi (Milan, Italy), I. Righi (Milan, Italy), S. Aliberti (Milan, Italy), P. Tarsia (Milan, Italy), N. Montano (Milan, Italy), F. Blasi (Milan, Italy)
| |
The diaphragm before and after lung transplant (LT)
A. LoMauro (Milan, Italy), A. Aliverti (Milan, Italy), E. Privitera (Milan, Italy), M. Vergari (Milan, Italy), I. Righi (Milan, Italy), M. Sgroia (Milan, Italy), D. Tosi (Milan, Italy), V. Rossetti (Milan, Italy), F. Briganti (Milan, Italy), P. Frykhol (Uppsala, Sweden), C. Colombo (Milan, Italy), M. Nosotti (Milan, Italy), A. Palleschi (Milan, Italy)
| |
Cardiopulmonary response to exercise after lung transplantation
M. Ulvestad (Oslo, Norway), M. Durheim (Oslo, Norway), M. Lund (Oslo, Norway), J. Kongerud (Oslo, Norway), S. Roterud (Oslo, Norway), E. Edvardsen (Oslo, Norway)
|  |
Physical activity, physical fitness and quality of life in lung transplant recipients
E. Edvardsen (Oslo, Norway), M. Ulvestad (Oslo, Norway), M. Lund (Oslo, Norway), J. Kongerud (Oslo, Norway), I. Alteren (Oslo, Norway), H. Flatsetøy (Oslo, Norway), V. Klungerbo (Oslo, Norway), S. Roterud (Oslo, Norway), M. Durheim (Oslo, Norway)
| |
Donor lung pathological abnormalities and recipient outcomes
D. Piloni (New York, United States of America), J. Costa (New York, United States of America), A. Urso (New York, United States of America), A. Gomez (New York, United States of America), L. Shah (New York, United States of America), H. Robbins (New York, United States of America), L. Benvenuto (New York, United States of America), J. Sonett (New York, United States of America), S. Arcasoy (New York, United States of America), F. D'Ovidio (New York, United States of America)
| |
Bronchial stenosis, a critical complication in lung transplant: single center experience
F. Tarantini (Bergamo, Italy), G. Ciaravino (Bergamo, Italy), P. Parigi (Bergamo, Italy), L. Novelli (Bergamo, Italy), L. Corbetta (Firenze, Italy)
| |
The role of pulmonary arterial wedge pressure in primary graft dysfunction
F. Blasi (Milan, Italy), L. Morlacchi (Milan, Italy), V. Rossetti (Milan, Italy), R. Casella (Milan, Italy), P. Tarsia (Milan, Italy), M. Nosotti (Milan, Italy), L. Rosso (Milan, Italy), P. Mendogni (Milan, Italy), F. Lombardi (Milan, Italy), M. Vicenzi (Milan, Italy)
| |
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
V. Mora Cuesta (Santander, Spain), D. Iturbe (Santander, Spain), L. González (Santander, Spain), T. Díaz (Santander, Spain), S. Fernández (Santander, Spain), A. Martínez (Santander, Spain), A. Sangrador (Santander, Spain), J. Gómez (Santander, Spain), A. Azueta (Santander, Spain), L. Sánchez (Santander, Spain), S. Naranjo (Santander, Spain), C. Álvarez (Santander, Spain), M. Carbajo (Santander, Spain), R. Mons (Santander, Spain), R. Alonso (Madrid, Spain), V. Pérez (Madrid, Spain), A. De Pablo (Madrid, Spain), J. Cifrián (Santander, Spain)
| |
Differential gene expression of aquaporins (AQP) in lung transplant recipients with acute lung rejection.
D. Magouliotis (Larissa, Greece), V. Tasiopoulou (Larissa, Greece), K. Spiliopoulos (Larissa, Greece), K. Svokos (Providence, RI, United States of America), A. Svokos (Newport News, VA, United States of America), K. Athanassiadi (Athens, Greece)
| |
Retrospective analysis of efficacy of combined CMV prophylaxis scheme: Turin Lung Transplant Center experience
F. Patrucco (Turin, Italy), E. Clivati (Turin, Italy), G. Verri (Turin, Italy), E. Simonato (Turin, Italy), D. Libertucci (Turin, Italy), C. Costa (Turin, Italy), A. Curtoni (Turin, Italy), M. Boffini (Turin, Italy), M. Rinaldi (Turin, Italy), C. Bucca (Turin, Italy), P. Solidoro (Turin, Italy)
| |
COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
S. Campos Silva (Lisboa, Portugal), N. Caires (Lisboa, Portugal), V. Caldeira (Lisboa, Portugal), R. Dias Coelho (Lisboa, Portugal), A. Santos (Lisboa, Portugal), T. Lopes (Lisboa, Portugal), P. Calvinho (Lisboa, Portugal), L. Semedo (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal), J. Fragata (Lisboa, Portugal)
| |
Outcomes and survival in alpha1-antitrypsin deficiency post lung transplantation
L. Khorsheed (Dublin, Ireland), I. Lawrie (Dublin, Ireland), S. Winward (Dublin, Ireland), K. Redmond (Dublin, Ireland), D. Eaton (Dublin, Ireland), D. Healy (Dublin, Ireland), L. Nolke (Dublin, Ireland), S. Javadpour (Dublin, Ireland), J. Egan (Dublin, Ireland), J. Kleinerova (Dublin, Ireland)
| |
Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.
M. Entrenas Castillo (Cordoba, Spain), I. OrdoñEz Dios (Cordoba, Spain), F. Montoro Ballesteros (Cordoba, Spain), J. Redel Montero (Cordoba, Spain), M. Cobos Ceballos (Cordoba, Spain), F. Santos Luna (Cordoba, Spain), J. Vaquero Barrios (Cordoba, Spain)
| |
Incidence and risk factors for bronchiolitis obliterans syndrome stage 0p after lung transplantation
S. Kwak (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), S. Moon (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea), J. Park (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), H. Paik (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea)
| |
Malignancies in lung transplant recipients: un update of the portuguese experience
V. Pereira Caldeira (Lisbon, Portugal), T. Sá (Lisbon, Portugal), S. Silva (Lisbon, Portugal), N. Caires (Lisbon, Portugal), R. Coelho (Lisbon, Portugal), S. Alfarroba (Lisbon, Portugal), A. Santos (Lisbon, Portugal), L. Semedo (Lisbon, Portugal), J. Cardoso (Lisbon, Portugal), J. Fragata (Lisbon, Portugal)
| |
Experience of lung transplant consultation in a non-transplant centre
M. Macia Palazon (Palma de Mallorca, Spain), A. Román Broto (Barcelona, Spain), E. Sala Llinas (Palma de Mallorca, Spain), C. Berastegui García (Barcelona, Spain), M. López Meseguer (Barcelona, Spain), J. Sauleda Roig (Palma de Mallorca, Spain)
| |